Literature DB >> 29619614

TNFα and IL-1β but not IL-18 Suppresses Hippocampal Long-Term Potentiation Directly at the Synapse.

G Aleph Prieto1, Liqi Tong2, Erica D Smith2, Carl W Cotman2.   

Abstract

CNS inflammatory responses are linked to cognitive impairment in humans. Research in animal models supports this connection by showing that inflammatory cytokines suppress long-term potentiation (LTP), the best-known cellular correlate of memory. Cytokine-induced modulation of LTP has been previously studied in vivo or in brain slices, two experimental approaches containing multiple cell populations responsive to cytokines. In their target cells, cytokines commonly increase the expression of multiple cytokines, thus increasing the complexity of brain cytokine networks even after single-cytokine challenges. Whether cytokines suppress LTP by direct effects on neurons or by indirect mechanisms is still an open question. Here, we evaluated the effect of a major set of inflammatory cytokines including tumor necrosis factor-α (TNFα), interleukin-1β (IL-1β) and interleukin-18 (IL-18) on chemically-induced LTP (cLTP) in isolated hippocampal synaptosomes of mice, using fluorescence analysis of single-synapse long-term potentiation (FASS-LTP). We found that TNFα and IL-1β suppress synaptosomal cLTP. In contrast, cLTP was not affected by IL-18, at a concentration previously shown to block LTP in hippocampal slices. We also found that IL-18 does not impair cLTP or brain-derived neurotrophic factor (BDNF) signaling in primary hippocampal neuronal cultures. Thus, using both synaptosomes and neuron cultures, our data suggest that IL-18 impairs LTP by indirect mechanisms, which may depend on non-neuronal cells, such as glia. Notably, our results demonstrate that TNFα and IL-1β directly suppress hippocampal plasticity via neuron-specific mechanisms. A better understanding of the brain's cytokine networks and their final molecular effectors is crucial to identify specific targets for intervention.

Entities:  

Keywords:  Cytokines; FASS-LTP; Hippocampus; Inflammation; Synaptosomes; cLTP

Mesh:

Substances:

Year:  2018        PMID: 29619614      PMCID: PMC6170724          DOI: 10.1007/s11064-018-2517-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  111 in total

1.  Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons.

Authors:  W Lu; H Man; W Ju; W S Trimble; J F MacDonald; Y T Wang
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 2.  A practical approach to multicolor flow cytometry for immunophenotyping.

Authors:  N Baumgarth; M Roederer
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

Review 3.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

4.  Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons.

Authors:  Heng-Ye Man; Qinhua Wang; Wei-Yang Lu; William Ju; Gholamreza Ahmadian; Lidong Liu; Sandra D'Souza; T P Wong; C Taghibiglou; Jie Lu; Larry E Becker; Lin Pei; Fang Liu; Matthias P Wymann; John F MacDonald; Yu Tian Wang
Journal:  Neuron       Date:  2003-05-22       Impact factor: 17.173

5.  The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases.

Authors:  E Vereker; E O'Donnell; M A Lynch
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism.

Authors:  Harald Neumann; Rudiger Schweigreiter; Toshihide Yamashita; Katja Rosenkranz; Hartmut Wekerle; Yves-Alain Barde
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

7.  The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro.

Authors:  B Curran; J J O'Connor
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

8.  Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia.

Authors:  E Tarkowski; K Blennow; A Wallin; A Tarkowski
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

Review 9.  Cytokine signals propagate through the brain.

Authors:  L Vitkovic; J P Konsman; J Bockaert; R Dantzer; V Homburger; C Jacque
Journal:  Mol Psychiatry       Date:  2000-11       Impact factor: 15.992

10.  Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia.

Authors:  W J Friedman
Journal:  Exp Neurol       Date:  2001-03       Impact factor: 5.330

View more
  18 in total

1.  Lipopolysaccharide-Induced Microglial Neuroinflammation: Attenuation by FK866.

Authors:  Yaling Xu; Lijia Yu; Ying Liu; Xiaohui Tang; Xijin Wang
Journal:  Neurochem Res       Date:  2021-03-13       Impact factor: 3.996

2.  Tumor Necrosis Factor-Alpha Alters Electrophysiological Properties of Rabbit Hippocampal Neurons.

Authors:  Desheng Wang
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Microglia modulate hippocampal synaptic transmission and sleep duration along the light/dark cycle.

Authors:  Giorgio Corsi; Katherine Picard; Maria Amalia di Castro; Stefano Garofalo; Federico Tucci; Giuseppina Chece; Claudio Del Percio; Maria Teresa Golia; Marcello Raspa; Ferdinando Scavizzi; Fanny Decoeur; Clotilde Lauro; Mara Rigamonti; Fabio Iannello; Davide Antonio Ragozzino; Eleonora Russo; Giovanni Bernardini; Agnès Nadjar; Marie Eve Tremblay; Claudio Babiloni; Laura Maggi; Cristina Limatola
Journal:  Glia       Date:  2021-09-06       Impact factor: 8.073

Review 4.  A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.

Authors:  Shaomin Li; Dennis J Selkoe
Journal:  J Neurochem       Date:  2020-04-05       Impact factor: 5.372

Review 5.  GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review.

Authors:  Jianheng Chen; Qian Li; Jiang Zhu; Zijing Yuan; Tao Wang; Jie Song
Journal:  Neurotox Res       Date:  2021-09-10       Impact factor: 3.911

6.  Circulating Agonist Autoantibody to 5-Hydroxytryptamine 2A Receptor in Lean and Diabetic Fatty Zucker Rat Strains.

Authors:  M B Zimering; M Grinberg; J Burton; Kch Pang
Journal:  Endocrinol Diabetes Metab J       Date:  2020-08-28

Review 7.  Inflammation: the link between comorbidities, genetics, and Alzheimer's disease.

Authors:  Estella A Newcombe; Judith Camats-Perna; Mallone L Silva; Nicholas Valmas; Tee Jong Huat; Rodrigo Medeiros
Journal:  J Neuroinflammation       Date:  2018-09-24       Impact factor: 8.322

Review 8.  Distinguishing normal brain aging from the development of Alzheimer's disease: inflammation, insulin signaling and cognition.

Authors:  Paul Denver; Paula L McClean
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

Review 9.  Neuroinflammation in Sepsis: Molecular Pathways of Microglia Activation.

Authors:  Carolina Araújo Moraes; Camila Zaverucha-do-Valle; Renaud Fleurance; Tarek Sharshar; Fernando Augusto Bozza; Joana d'Avila
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

10.  Chemical Stimulation of Rodent and Human Cortical Synaptosomes: Implications in Neurodegeneration.

Authors:  Faraz Ahmad; Yu Jing; Albert Lladó; Ping Liu
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.